McCune Albright syndrome
McCune-Albright Syndrome
McCune-Albright Syndrome (pronunciation: məˈkjuːn ˈælbraɪt ˈsɪndrəʊm) is a complex genetic disorder affecting the skin, bones, and endocrine system. The syndrome was first described by Donovan James McCune and Fuller Albright in 1937.
Etymology
The syndrome is named after the two physicians, Donovan James McCune and Fuller Albright, who first described the condition in detail.
Symptoms
The symptoms of McCune-Albright Syndrome can vary greatly from person to person. They may include fibrous dysplasia, café-au-lait spots, and precocious puberty. Other symptoms can include hyperthyroidism, Cushing's syndrome, and acromegaly.
Diagnosis
Diagnosis of McCune-Albright Syndrome is typically based on the presence of at least two of the three main symptoms: fibrous dysplasia, café-au-lait spots, and precocious puberty. Genetic testing can also be used to confirm the diagnosis.
Treatment
Treatment for McCune-Albright Syndrome is typically focused on managing symptoms and may include surgery, medication, and/or hormone therapy.
Prognosis
The prognosis for individuals with McCune-Albright Syndrome can vary greatly depending on the severity of symptoms. Some individuals may live relatively normal lives, while others may experience significant health challenges.
See Also
External links
- Medical encyclopedia article on McCune Albright syndrome
- Wikipedia's article - McCune Albright syndrome
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski